Skip to main content
Holiday Sale — Get 40% off Vantage for yourself or as a gift
Published loading...Updated

U.S. FDA removes COVID test requirements for Pfizer, Merck pills

Summary by Ground News
Pfizer's Paxlovid and Merck's Lagevrio pills were given emergency use authorizations in Dec. 2021. FDA said the patients should have a current diagnosis of mild-to-moderate COVID infection. Individuals with recent known exposure with signs and symptoms may be diagnosed by their healthcare providers with COVID even if they have a negative test result.

Bias Distribution

  • 67% of the sources are Center
67% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Reuters broke the news in United Kingdom on Wednesday, February 1, 2023.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal